POST LEONARD E

CIK 00012358625 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001235862

Recent Transactions

50 trades

Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-11-17$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-11-17−1,000→ 117,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-11-17$41.43/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-10-13−1,000→ 118,077 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-10-13$0.60/sh+1,000→ 1,000 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-10-13$43.25/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-09-30−5,000→ 119,077 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-09-30$0.60/sh+5,000→ 5,000 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-30$40.09/sh−5,000→ 0 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-15$35.10/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-09-15−1,000→ 124,077 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-09-15$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-09-03−1,000→ 125,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-03$28.00/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-09-03$0.60/sh+1,000→ 1,000 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-07-17$28.00/sh−2,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-07-17$0.60/sh+2,000→ 2,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-07-17−2,000→ 126,077 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2025-06-20$14.45/sh−2,112→ 29,937 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2025-06-11+15,630→ 15,630 total
Award
uniQure N.V.$QURE
Ordinary Shares
2025-06-11+7,970→ 32,049 total
Award
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-06-05+24,165→ 24,165 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-05-21$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-05-21−1,000→ 128,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-05-21$28.00/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-04-28−1,000→ 129,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-04-28$30.76/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-04-28$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-03-17$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-03-17−1,000→ 130,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-03-17$28.00/sh−1,000→ 0 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-02-18$28.61/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-02-18$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-02-18−1,000→ 131,077 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-01-13$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-01-13−1,000→ 132,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-01-13$29.66/sh−1,000→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2024-12-16$0.60/sh+1,000→ 1,000 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Stock Option
2024-12-16−1,000→ 133,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2024-12-16$28.84/sh−1,000→ 0 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2024-12-06$34.40/sh−750→ 250 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Stock Option
2024-12-06−1,000→ 134,077 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2024-12-06$34.98/sh−250→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2024-12-06$0.60/sh+1,000→ 1,000 total
Award
CG Oncology, Inc.$CGON
Stock Option (Right to Buy)
2024-10-04+15,600→ 15,600 total
Award
uniQure N.V.$QURE
Ordinary Shares
2024-06-19+8,080→ 24,079 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2024-06-19+15,840→ 15,840 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2024-06-13$5.14/sh−2,222→ 15,999 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2023-06-16$18.83/sh−2,291→ 18,221 total
Award
uniQure N.V.$QURE
Ordinary Shares
2023-06-13+8,700→ 20,512 total

Companies

Recent Filings

Address

C/O CG ONCOLOGY, INC. 400 SPECTRUM CENTER DRIVE, SUITE 2040

IRVINE, CA, 92618

View on SEC.gov